Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Arnold

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levelsAllan F Moore, Tamara L Wexler, Rachel L Yung, et al.
Endocrine Research|February 25, 2016
Modeling vitamin D insufficiency and moderate deficiency in adult mice via dietary cholecalciferol restrictionSanjay M Mallya, Kristin R Corrado, Elizabeth A Saria, et al.
JAMA|March 17, 2005
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trialEva Lonn, Jackie Bosch, Salim Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancerSimon J Crabb, Demetris Patsios, Eric Sauerbrei, et al.
Endocrinology|September 11, 2023
Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid TumorigenesisJessica Costa-Guda, Kristin Corrado, Justin Bellizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2019
Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid AdenomasAaliyah Riccardi, Tori Aspir, Lilia Shen, et al.
Journal of the American Society of Nephrology : JASN|June 1, 2002
Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremiaYasuo Imanishi, Hideki Tahara, Nallasivam Palanisamy, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2021
GCM2 Variants in Familial and Multiglandular Primary HyperparathyroidismSarah Vincze, Nicholas V Peters, Chia-Ling Kuo, et al.
Journal of Bone and Mineral Metabolism|February 17, 2026
Evocalcet improved the PTH-calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidismYasuo Imanishi, Tomoe Hirakawa, Waka Haruyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levelsAllan F Moore, Tamara L Wexler, Rachel L Yung, et al.
Endocrine Research|February 25, 2016
Modeling vitamin D insufficiency and moderate deficiency in adult mice via dietary cholecalciferol restrictionSanjay M Mallya, Kristin R Corrado, Elizabeth A Saria, et al.
JAMA|March 17, 2005
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trialEva Lonn, Jackie Bosch, Salim Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancerSimon J Crabb, Demetris Patsios, Eric Sauerbrei, et al.
Endocrinology|September 11, 2023
Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid TumorigenesisJessica Costa-Guda, Kristin Corrado, Justin Bellizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2019
Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid AdenomasAaliyah Riccardi, Tori Aspir, Lilia Shen, et al.
Journal of the American Society of Nephrology : JASN|June 1, 2002
Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremiaYasuo Imanishi, Hideki Tahara, Nallasivam Palanisamy, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2021
GCM2 Variants in Familial and Multiglandular Primary HyperparathyroidismSarah Vincze, Nicholas V Peters, Chia-Ling Kuo, et al.
Journal of Bone and Mineral Metabolism|February 17, 2026
Evocalcet improved the PTH-calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidismYasuo Imanishi, Tomoe Hirakawa, Waka Haruyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Pageof 9